Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis

Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis

Background: chemotherapy response score (CRS) is widely used to assess the response of ovarian high-grade serous carcinoma (HGSC) to chemotherapy and is based on pathological examination of omental specimens. We aimed to assess the prognostic value of CRS assessed on the uterine adnexa. Methods: a s...

Full description

Bibliographic Details
Main Authors: Angela Santoro, Antonio Travaglino, Frediano Inzani, Patrizia Straccia, Damiano Arciuolo, Michele Valente, Nicoletta D’Alessandris, Giulia Scaglione, Giuseppe Angelico, Alessia Piermattei, Federica Cianfrini, Antonio Raffone, Gian Franco Zannoni
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Diagnostics
Subjects:
ovarian cancer
chemotherapy
CRS
high grade serous carcinoma
prognosis
Online Access:https://www.mdpi.com/2075-4418/12/3/633

Internet

https://www.mdpi.com/2075-4418/12/3/633

Similar Items